The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

I just hit 20,000 steps!" my husband exclaims as he brags when his fitness tracker exceeds the oft-heard benchmark of 10,000 ...

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is starting the new year with its first approved drug. The company received notice from the U.S. Food and Drug ...